DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Apricus Biosciences, Inc.

31.08.2011 15:47
—————————————————————————

SAN DIEGO, 2011-08-31 15:47 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that its wholly-owned subsidiary,
NexMed USA, Inc., has received clearance from the U.S. Food and Drug
Administration (–FDA–) for its third, over-the-counter (–OTC–) drug,
Diphenhydramine-D(tm), conta